Aadi Bioscience (AADI) Competitors $2.39 +0.03 (+1.27%) (As of 12:33 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AADI vs. SLDB, BNTC, STRO, CMPX, ACRV, DMAC, ADCT, SOPH, XBIT, and INBXShould you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include Solid Biosciences (SLDB), Benitec Biopharma (BNTC), Sutro Biopharma (STRO), Compass Therapeutics (CMPX), Acrivon Therapeutics (ACRV), DiaMedica Therapeutics (DMAC), ADC Therapeutics (ADCT), SOPHiA GENETICS (SOPH), XBiotech (XBIT), and Inhibrx (INBX). These companies are all part of the "pharmaceutical products" industry. Aadi Bioscience vs. Solid Biosciences Benitec Biopharma Sutro Biopharma Compass Therapeutics Acrivon Therapeutics DiaMedica Therapeutics ADC Therapeutics SOPHiA GENETICS XBiotech Inhibrx Solid Biosciences (NASDAQ:SLDB) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, community ranking, dividends, valuation and analyst recommendations. Do insiders and institutionals hold more shares of SLDB or AADI? 81.5% of Solid Biosciences shares are owned by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are owned by institutional investors. 13.6% of Solid Biosciences shares are owned by company insiders. Comparatively, 37.3% of Aadi Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is SLDB or AADI more profitable? Solid Biosciences has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. Solid Biosciences' return on equity of -58.75% beat Aadi Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Solid BiosciencesN/A -58.75% -47.84% Aadi Bioscience -246.06%-71.87%-57.28% Which has higher earnings and valuation, SLDB or AADI? Aadi Bioscience has higher revenue and earnings than Solid Biosciences. Solid Biosciences is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolid Biosciences$8.09M28.60-$96.01M-$3.04-1.90Aadi Bioscience$25.07M2.32-$65.76M-$2.28-1.04 Does the MarketBeat Community favor SLDB or AADI? Solid Biosciences received 253 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 68.39% of users gave Solid Biosciences an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformSolid BiosciencesOutperform Votes26468.39% Underperform Votes12231.61% Aadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% Do analysts rate SLDB or AADI? Solid Biosciences presently has a consensus price target of $15.14, suggesting a potential upside of 161.53%. Aadi Bioscience has a consensus price target of $1.67, suggesting a potential downside of 29.38%. Given Solid Biosciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Solid Biosciences is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solid Biosciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, SLDB or AADI? Solid Biosciences has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Does the media prefer SLDB or AADI? In the previous week, Aadi Bioscience had 1 more articles in the media than Solid Biosciences. MarketBeat recorded 5 mentions for Aadi Bioscience and 4 mentions for Solid Biosciences. Aadi Bioscience's average media sentiment score of 1.67 beat Solid Biosciences' score of 1.19 indicating that Aadi Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solid Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aadi Bioscience 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummarySolid Biosciences beats Aadi Bioscience on 12 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But here’s the thing: most people won’t be able to keep up with the pace of the market. That’s why I want to tell you about WaveBot – an automated trading tool created by my good friends Joel and Adam.Register for the FREE Workshop Now & get $10 in Bitcoin Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AADI vs. The Competition Export to ExcelMetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.17M$6.73B$5.23B$8.96BDividend YieldN/A7.94%5.24%4.05%P/E Ratio-1.045.7998.6914.63Price / Sales2.32381.601,484.9296.07Price / CashN/A62.3741.8238.51Price / Book0.858.116.116.18Net Income-$65.76M$152.00M$117.65M$224.75M7 Day Performance2.16%3.31%2.86%1.98%1 Month Performance18.59%-1.52%1.79%9.78%1 Year Performance-52.71%31.57%35.89%29.97% Aadi Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AADIAadi Bioscience2.2428 of 5 stars$2.39+1.3%$1.67-30.3%-52.7%$58.91M$24.35M-1.0540Short Interest ↓News CoveragePositive NewsSLDBSolid Biosciences3.544 of 5 stars$5.79+1.6%$15.14+161.5%+92.4%$231.37M$8.09M-1.88100Gap UpBNTCBenitec Biopharma3.0347 of 5 stars$9.95-1.4%$22.60+127.1%+203.1%$231.04M$80,000.000.0020Analyst ForecastPositive NewsSTROSutro Biopharma4.6534 of 5 stars$2.79+5.3%$12.14+335.2%+0.0%$230.06M$153.73M-1.65240Positive NewsGap UpCMPXCompass Therapeutics3.5458 of 5 stars$1.67+2.5%$6.75+304.2%-1.8%$229.77M$850,000.00-4.4920Positive NewsACRVAcrivon Therapeutics2.6225 of 5 stars$7.37-2.8%$23.67+221.1%+68.7%$229.47MN/A-2.8158Positive NewsDMACDiaMedica Therapeutics2.4775 of 5 stars$5.29-6.5%$7.00+32.3%+106.2%$226.20MN/A-9.3620Positive NewsGap DownHigh Trading VolumeADCTADC Therapeutics2.1982 of 5 stars$2.32-4.1%$8.25+255.6%+109.0%$224.32M$70.72M-1.01310SOPHSOPHiA GENETICS1.8253 of 5 stars$3.42+0.3%$6.50+90.1%-15.4%$223.58M$64.49M-3.09520XBITXBiotech0.5659 of 5 stars$7.27-4.5%N/A+79.6%$221.59M$4.01M0.00100INBXInhibrx1.2867 of 5 stars$15.27+0.1%N/A-32.6%$221.05M$1.57M0.00166Short Interest ↑Positive NewsGap Up Related Companies and Tools Related Companies SLDB Competitors BNTC Competitors STRO Competitors CMPX Competitors ACRV Competitors DMAC Competitors ADCT Competitors SOPH Competitors XBIT Competitors INBX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AADI) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
